Reuters logo
BRIEF-Delmar Pharmaceuticals names Saiid Zarrabian interim CEO
November 7, 2017 / 9:28 PM / 13 days ago

BRIEF-Delmar Pharmaceuticals names Saiid Zarrabian interim CEO

Nov 7 (Reuters) - Delmar Pharmaceuticals Inc

* Delmar Pharmaceuticals appoints Saiid Zarrabian as interim chief executive officer

* Jeffrey Bacha, cofounder of Co, will continue in role as president and in newly created position of chief operating officer​

* Zarrabian and Bacha will continue to serve on company’s board of directors​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below